IBDEI0IY ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19101,1,4,0)
 ;;=4^I71.4
 ;;^UTILITY(U,$J,358.3,19101,2)
 ;;=^5007789
 ;;^UTILITY(U,$J,358.3,19102,0)
 ;;=I73.9^^86^981^19
 ;;^UTILITY(U,$J,358.3,19102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19102,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,19102,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,19102,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,19103,0)
 ;;=I82.891^^86^981^14
 ;;^UTILITY(U,$J,358.3,19103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19103,1,3,0)
 ;;=3^Embolism/Thrombosis Oth Spec Veins,Chronic
 ;;^UTILITY(U,$J,358.3,19103,1,4,0)
 ;;=4^I82.891
 ;;^UTILITY(U,$J,358.3,19103,2)
 ;;=^5007939
 ;;^UTILITY(U,$J,358.3,19104,0)
 ;;=I82.890^^86^981^13
 ;;^UTILITY(U,$J,358.3,19104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19104,1,3,0)
 ;;=3^Embolism/Thrombosis Oth Spec Veins,Acute
 ;;^UTILITY(U,$J,358.3,19104,1,4,0)
 ;;=4^I82.890
 ;;^UTILITY(U,$J,358.3,19104,2)
 ;;=^5007938
 ;;^UTILITY(U,$J,358.3,19105,0)
 ;;=E78.0^^86^982^12
 ;;^UTILITY(U,$J,358.3,19105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19105,1,3,0)
 ;;=3^Pure Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,19105,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,19105,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,19106,0)
 ;;=E78.1^^86^982^13
 ;;^UTILITY(U,$J,358.3,19106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19106,1,3,0)
 ;;=3^Pure Hyperglyceridemia
 ;;^UTILITY(U,$J,358.3,19106,1,4,0)
 ;;=4^E78.1
 ;;^UTILITY(U,$J,358.3,19106,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,19107,0)
 ;;=E78.2^^86^982^11
 ;;^UTILITY(U,$J,358.3,19107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19107,1,3,0)
 ;;=3^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,19107,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,19107,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,19108,0)
 ;;=I10.^^86^982^3
 ;;^UTILITY(U,$J,358.3,19108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19108,1,3,0)
 ;;=3^Essential Primary Hypertension
 ;;^UTILITY(U,$J,358.3,19108,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,19108,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,19109,0)
 ;;=I11.9^^86^982^10
 ;;^UTILITY(U,$J,358.3,19109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19109,1,3,0)
 ;;=3^Hypertensive Heart Disease w/o Heart Failure
 ;;^UTILITY(U,$J,358.3,19109,1,4,0)
 ;;=4^I11.9
 ;;^UTILITY(U,$J,358.3,19109,2)
 ;;=^5007064
 ;;^UTILITY(U,$J,358.3,19110,0)
 ;;=I11.0^^86^982^9
 ;;^UTILITY(U,$J,358.3,19110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19110,1,3,0)
 ;;=3^Hypertensive Heart Disease w/ Heart Failure
 ;;^UTILITY(U,$J,358.3,19110,1,4,0)
 ;;=4^I11.0
 ;;^UTILITY(U,$J,358.3,19110,2)
 ;;=^5007063
 ;;^UTILITY(U,$J,358.3,19111,0)
 ;;=I12.0^^86^982^8
 ;;^UTILITY(U,$J,358.3,19111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19111,1,3,0)
 ;;=3^Hypertensive Chr Kidney Disease w/ ESRD
 ;;^UTILITY(U,$J,358.3,19111,1,4,0)
 ;;=4^I12.0
 ;;^UTILITY(U,$J,358.3,19111,2)
 ;;=^5007065
 ;;^UTILITY(U,$J,358.3,19112,0)
 ;;=I13.10^^86^982^6
 ;;^UTILITY(U,$J,358.3,19112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19112,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/o Hrt Fail w/ Stg 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,19112,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,19112,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,19113,0)
 ;;=I13.0^^86^982^4
 ;;^UTILITY(U,$J,358.3,19113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19113,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/ Hrt Fail w/ Stg 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,19113,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,19113,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,19114,0)
 ;;=I13.11^^86^982^7
 ;;^UTILITY(U,$J,358.3,19114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19114,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/o Hrt Fail w/ Stg 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,19114,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,19114,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,19115,0)
 ;;=I13.2^^86^982^5
 ;;^UTILITY(U,$J,358.3,19115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19115,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/ Hrt Fail w/ Stg 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,19115,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,19115,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,19116,0)
 ;;=I48.91^^86^982^1
 ;;^UTILITY(U,$J,358.3,19116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19116,1,3,0)
 ;;=3^Atrial Fibrillation,Unspec
 ;;^UTILITY(U,$J,358.3,19116,1,4,0)
 ;;=4^I48.91
 ;;^UTILITY(U,$J,358.3,19116,2)
 ;;=^5007229
 ;;^UTILITY(U,$J,358.3,19117,0)
 ;;=I48.92^^86^982^2
 ;;^UTILITY(U,$J,358.3,19117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19117,1,3,0)
 ;;=3^Atrial Flutter,Unspec
 ;;^UTILITY(U,$J,358.3,19117,1,4,0)
 ;;=4^I48.92
 ;;^UTILITY(U,$J,358.3,19117,2)
 ;;=^5007230
 ;;^UTILITY(U,$J,358.3,19118,0)
 ;;=B07.9^^86^983^288
 ;;^UTILITY(U,$J,358.3,19118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19118,1,3,0)
 ;;=3^Viral Wart,Unspec
 ;;^UTILITY(U,$J,358.3,19118,1,4,0)
 ;;=4^B07.9
 ;;^UTILITY(U,$J,358.3,19118,2)
 ;;=^5000519
 ;;^UTILITY(U,$J,358.3,19119,0)
 ;;=A63.0^^86^983^34
 ;;^UTILITY(U,$J,358.3,19119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19119,1,3,0)
 ;;=3^Anogenital (Venereal) Warts
 ;;^UTILITY(U,$J,358.3,19119,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,19119,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,19120,0)
 ;;=B35.0^^86^983^279
 ;;^UTILITY(U,$J,358.3,19120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19120,1,3,0)
 ;;=3^Tinea Barbae and Tinea Capitis
 ;;^UTILITY(U,$J,358.3,19120,1,4,0)
 ;;=4^B35.0
 ;;^UTILITY(U,$J,358.3,19120,2)
 ;;=^5000604
 ;;^UTILITY(U,$J,358.3,19121,0)
 ;;=B35.1^^86^983^284
 ;;^UTILITY(U,$J,358.3,19121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19121,1,3,0)
 ;;=3^Tinea Unguium
 ;;^UTILITY(U,$J,358.3,19121,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,19121,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,19122,0)
 ;;=B35.6^^86^983^281
 ;;^UTILITY(U,$J,358.3,19122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19122,1,3,0)
 ;;=3^Tinea Cruris
 ;;^UTILITY(U,$J,358.3,19122,1,4,0)
 ;;=4^B35.6
 ;;^UTILITY(U,$J,358.3,19122,2)
 ;;=^119711
 ;;^UTILITY(U,$J,358.3,19123,0)
 ;;=B35.3^^86^983^283
 ;;^UTILITY(U,$J,358.3,19123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19123,1,3,0)
 ;;=3^Tinea Pedis
 ;;^UTILITY(U,$J,358.3,19123,1,4,0)
 ;;=4^B35.3
 ;;^UTILITY(U,$J,358.3,19123,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,19124,0)
 ;;=B35.5^^86^983^282
 ;;^UTILITY(U,$J,358.3,19124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19124,1,3,0)
 ;;=3^Tinea Imbricata
 ;;^UTILITY(U,$J,358.3,19124,1,4,0)
 ;;=4^B35.5
 ;;^UTILITY(U,$J,358.3,19124,2)
 ;;=^119725
 ;;^UTILITY(U,$J,358.3,19125,0)
 ;;=B35.4^^86^983^280
 ;;^UTILITY(U,$J,358.3,19125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19125,1,3,0)
 ;;=3^Tinea Corporis
 ;;^UTILITY(U,$J,358.3,19125,1,4,0)
 ;;=4^B35.4
 ;;^UTILITY(U,$J,358.3,19125,2)
 ;;=^119704
 ;;^UTILITY(U,$J,358.3,19126,0)
 ;;=B35.8^^86^983^137
 ;;^UTILITY(U,$J,358.3,19126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19126,1,3,0)
 ;;=3^Dermatophytoses,Other
 ;;^UTILITY(U,$J,358.3,19126,1,4,0)
 ;;=4^B35.8
 ;;^UTILITY(U,$J,358.3,19126,2)
 ;;=^5000606
 ;;^UTILITY(U,$J,358.3,19127,0)
 ;;=B36.9^^86^983^272
 ;;^UTILITY(U,$J,358.3,19127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19127,1,3,0)
 ;;=3^Superficial Mycosis,Unspec
 ;;^UTILITY(U,$J,358.3,19127,1,4,0)
 ;;=4^B36.9
 ;;^UTILITY(U,$J,358.3,19127,2)
 ;;=^5000611
 ;;^UTILITY(U,$J,358.3,19128,0)
 ;;=D69.0^^86^983^32
 ;;^UTILITY(U,$J,358.3,19128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19128,1,3,0)
 ;;=3^Allergic Purpura
 ;;^UTILITY(U,$J,358.3,19128,1,4,0)
 ;;=4^D69.0
 ;;^UTILITY(U,$J,358.3,19128,2)
 ;;=^5002365
 ;;^UTILITY(U,$J,358.3,19129,0)
 ;;=B00.9^^86^983^158
 ;;^UTILITY(U,$J,358.3,19129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19129,1,3,0)
 ;;=3^Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,19129,1,4,0)
 ;;=4^B00.9
 ;;^UTILITY(U,$J,358.3,19129,2)
 ;;=^5000480
 ;;^UTILITY(U,$J,358.3,19130,0)
 ;;=B02.9^^86^983^291
